Nondermatology doctors often underuse mainstays of therapy for atopic dermatitis

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
  • Nondermatologists often underuse mainstays of atopic dermatitis (AD) treatment, such as topical corticosteroids (TCS) and emollients.
Why this matters
  • AD is common in both adults and children. 
Study design
  • Authors used data from the 1993-2010 National Ambulatory Medical Care (NAMCS) and National Hospital Ambulatory Care (NHAMCS) surveys to assess visits made for AD and to analyze medication prescribed by dermatologists vs other nondermatologist physicians.
  • Funding: Galderma Laboratories, LP. 1 author has received grants/been a consultant for Galderma, Abbott Labs, and other companies. 
Key results
  • An estimated 3.7 million people visited doctors (outpatient office and hospital departments) for AD between 1993 and 2010.
  • In outpatient settings, visits were managed primarily by pediatricians (74%) and dermatologists (14%)...